##gff-version 3
##sequence-region Q695T7 1 634
Q695T7	UniProtKB	Chain	1	634	.	.	.	ID=PRO_0000214809;Note=Sodium-dependent neutral amino acid transporter B(0)AT1	
Q695T7	UniProtKB	Topological domain	1	41	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	42	62	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	63	67	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	68	88	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	89	120	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	121	141	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	142	192	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	193	213	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	214	221	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	222	242	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	243	268	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	269	289	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	290	304	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	305	325	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	326	413	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	414	434	.	.	.	Note=Helical%3B Name%3D8;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	435	456	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	457	477	.	.	.	Note=Helical%3B Name%3D9;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	478	490	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	491	511	.	.	.	Note=Helical%3B Name%3D10;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	512	531	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	532	552	.	.	.	Note=Helical%3B Name%3D11;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	553	581	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Transmembrane	582	602	.	.	.	Note=Helical%3B Name%3D12;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Topological domain	603	634	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Modified residue	17	17	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D687	
Q695T7	UniProtKB	Modified residue	627	627	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9D687	
Q695T7	UniProtKB	Glycosylation	158	158	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Glycosylation	182	182	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Glycosylation	258	258	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Glycosylation	354	354	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Glycosylation	368	368	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q695T7	UniProtKB	Natural variant	57	57	.	.	.	ID=VAR_023314;Note=In HND%3B no amino acid transport activity when expressed alone or coexpressed with CLTRN or ACE2%3B loss of surface expression when expressed alone or coexpressed with CLTRN or ACE2. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15286787,ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs762989809,PMID:15286787,PMID:19185582	
Q695T7	UniProtKB	Natural variant	66	66	.	.	.	ID=VAR_081070;Note=In HND%3B abolishes amino acid transport activity. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18484095;Dbxref=dbSNP:rs1251095994,PMID:18484095	
Q695T7	UniProtKB	Natural variant	69	69	.	.	.	ID=VAR_081071;Note=In HND%3B increases cell membrane localization in presence of ACE2 or CLTRN%3B does not affect interaction with ACE2%3B amino acid transport activity is not actived in presence of ACE2 or CLTRN. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185582;Dbxref=PMID:19185582	
Q695T7	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_081072;Note=In HND%3B no amino acid transport activity when expressed alone or coexpressed with CLTRN or ACE2%3B increases surface cell expression when expressed alone or coexpressed with CLTRN or ACE2. G->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18484095,ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs757679627,PMID:18484095,PMID:19185582	
Q695T7	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_023315;Note=In HND%3B population allele frequency among Europeans is 0.007%3B reduced transport activity by 50%25 but does not completely inactivates the transporter%3B coexpression with ACE2 increased the transport rate whereas coexpression with CLTRN has the opposite effect%3B does not affect interaction with ACE2%3B decreased cell membrane localization in presence of CLTRN. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15286788,ECO:0000269|PubMed:18484095;Dbxref=dbSNP:rs121434346,PMID:15286788,PMID:18484095	
Q695T7	UniProtKB	Natural variant	178	634	.	.	.	ID=VAR_081073;Note=In HND%3B abolishes amino acid transport activity. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18484095;Dbxref=PMID:18484095	
Q695T7	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_023316;Note=In HND%3B does not affect amino acid transport activity when expressed alone%3B decreases amino acid transport activity in presence of ACE2 or CLTRN%3B decreased surface cell expression when expressed with CLTRN or ACE2. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15286788,ECO:0000269|PubMed:18424768,ECO:0000269|PubMed:18484095,ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs758492838,PMID:15286788,PMID:18424768,PMID:18484095,PMID:19185582	
Q695T7	UniProtKB	Natural variant	242	242	.	.	.	ID=VAR_023317;Note=In HND%3B no amino acid transport activity when expressed alone or coexpressed with CLTRN or ACE2%3B loss of surface expression when expressed coexpressed with CLTRN or ACE2. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15286788,ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs200745023,PMID:15286788,PMID:19185582	
Q695T7	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_023318;Note=Does not affect cell membrane localization%3B does not affect amino acid transport activity. V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15286788,ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs7732589,PMID:15286788,PMID:19185582	
Q695T7	UniProtKB	Natural variant	265	265	.	.	.	ID=VAR_081074;Note=In HND%3B does not affect interaction with ACE2%3B coexpression with ACE2 increased the transport rate whereas coexpression with CLTRN has the opposite effect. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs148139045,PMID:19185582	
Q695T7	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_081075;Note=In HND%3B abolishes amino acid transport activity. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18484095;Dbxref=dbSNP:rs200842846,PMID:18484095	
Q695T7	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_081076;Note=In HND%3B abolishes amino acid transport activity. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18484095;Dbxref=dbSNP:rs142164435,PMID:18484095	
Q695T7	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_081077;Note=In HND%3B abolishes amino acid transport activity. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18484095;Dbxref=dbSNP:rs765501634,PMID:18484095	
Q695T7	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_023319;Note=In HND%3B no amino acid transport activity when expressed alone or coexpressed with CLTRN or ACE2%3B loss of surface expression when expressed alone or coexpressed with CLTRN or ACE2. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15286788,ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs1236852017,PMID:15286788,PMID:19185582	
Q695T7	UniProtKB	Natural variant	517	517	.	.	.	ID=VAR_081078;Note=In HND%3B abolishes amino acid transport activity. D->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18484095;Dbxref=dbSNP:rs745524993,PMID:18484095	
Q695T7	UniProtKB	Natural variant	579	579	.	.	.	ID=VAR_081079;Note=In HND%3B no amino acid transport activity when expressed alone or coexpressed with CLTRN or ACE2%3B loss of surface expression when expressed alone or coexpressed with CLTRN or ACE2. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19185582;Dbxref=dbSNP:rs751554174,PMID:19185582	
